Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

The Lancet - United Kingdom
doi 10.1016/s0140-6736(19)32503-6
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy